Australia at heart of cancer vaccine breakthrough for melanoma

An mRNA cancer vaccine for melanoma, the deadliest skin cancer, reportedly cut risk of recurrence or death by almost half in a clinical trial. Australian outlets describe it as 'transformational'.

Timeline

1. 22 Oct, 22:13 UTCFirst appeared on Ars Technica
2. 23 Oct, 01:08 UTCPicked up on News
3. 23 Oct, 08:00 UTCPicked up on Google Trends
4. 23 Oct, 08:00 UTCABC News covers Australian role in vaccine
5. 23 Oct, 08:00 UTCThe Guardian reports trial results

Top sources

• Personalized mRNA cancer vaccine cut melanoma death, recurrence by 42% Markers released top-line results today after preArs Technica
• georgina longGoogle Trends
• Breakthrough vaccine for the deadliest skin cancer cut risk by almost halfThe Washington Post
• Novel mRNA cancer vaccine helps reduce chances of melanoma patients' tumours returningGulf News
• Watch 9News Latest Stories - Season 2026 - Landmark cancer vaccine reduces risk of melanoma9Now
• ‘Landmark moment’: Sydney scientist’s world-first cancer breakthrough revealedSMH.com.au
• ‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial showsThe Guardian
• Australia helps develop world-first mRNA cancer vaccine for melanomaWAtoday